secwatch / observer

Executive movement radar

Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.

Launch 75308 grounded facts newest July 10, 2026, 2:16 PM ET RSS · JSON

Showing 351–400 of 75308

Departed

Craig Arnold

Director
HON · HONEYWELL INTERNATIONAL INC
Filed
June 15, 2026, 7:04 AM ET
On June 13, 2026, each of Messrs. Craig Arnold, William Ayer and D. Scott Davis and Ms. Deborah Flint notified the Board of Directors (the “ Board ”) of Honeywell International Inc. (the “ Company ”) that, in connection with the anticipated spin-off of the Company’s Aerospace Technologies business into an independent, publicly traded company (the “ Spin‐Off ”), he/she will be resigning from the Board
Departed

Deborah Flint

Director
HON · HONEYWELL INTERNATIONAL INC
Filed
June 15, 2026, 7:04 AM ET
On June 13, 2026, each of Messrs. Craig Arnold, William Ayer and D. Scott Davis and Ms. Deborah Flint notified the Board of Directors (the “ Board ”) of Honeywell International Inc. (the “ Company ”) that, in connection with the anticipated spin-off of the Company’s Aerospace Technologies business into an independent, publicly traded company (the “ Spin‐Off ”), he/she will be resigning from the Board
Departed

Kristen Johnson

Other Named Officer
HTO · H2O AMERICA
Effective
2026-07-03
Filed
June 12, 2026, 5:21 PM ET
On June 10, 2026, Kristen Johnson and the Company mutually agreed that Ms. Johnson will separate from the Company, effective July 3, 2026.
Departed

Nabil Hamade

director
SAIL · SailPoint, Inc.
Effective
2026-06-12
Successor
Collin Gallagher
Filed
June 12, 2026, 5:16 PM ET
On June 8, 2026, SailPoint, Inc. (the “Company”) was notified of Nabil Hamade’s decision to resign from the board of directors of the Company (the “Board”) effective as of June 12, 2026.
Departed

Rajeev Date

Director
CRCL · Circle Internet Group, Inc.
Effective
2026-06-12
Filed
June 12, 2026, 5:01 PM ET
On June 12, 2026, Rajeev Date tendered his resignation to the Board of Directors (the “Board”) of Circle Internet Group, Inc. (the “Company”), effective immediately, for personal reasons.
Departed

Nickolay Kukekov

Director
BRTX · BioRestorative Therapies, Inc.
Effective
2026-06-11
Filed
June 12, 2026, 4:56 PM ET
Effective June 11, 2026, pursuant to the Revolving Loan Agreement, Francisco Silva, Nickolay Kukekov and Patrick F. Williams resigned as directors of the Company.
Departed

Francisco Silva

Director
BRTX · BioRestorative Therapies, Inc.
Effective
2026-06-11
Filed
June 12, 2026, 4:56 PM ET
Effective June 11, 2026, pursuant to the Revolving Loan Agreement, Francisco Silva, Nickolay Kukekov and Patrick F. Williams resigned as directors of the Company.
Departed

Patrick F. Williams

Director
BRTX · BioRestorative Therapies, Inc.
Effective
2026-06-11
Filed
June 12, 2026, 4:56 PM ET
Effective June 11, 2026, pursuant to the Revolving Loan Agreement, Francisco Silva, Nickolay Kukekov and Patrick F. Williams resigned as directors of the Company.
Departed

Matthew Faber

Director
TYFG · Tri-County Financial Group, Inc.
Effective
2026-06-11
Filed
June 12, 2026, 4:36 PM ET
On June 9, 2026, Matthew Faber informed Tri-County Financial Group, Inc. (the “Company”) of his intent to resign from the Company’s Board of Directors (the “Board”), which became effective June 11, 2026.
Departed

Fraser McNamee

Manager, Secretary and Treasurer
Empire District Bondco, LLC
Effective
2026-06-10
Successor
Robert Stefani
Filed
June 12, 2026, 4:35 PM ET
Effective June 10, 2026, Fraser McNamee, formerly Manager, Secretary and Treasurer of Empire District Bondco, LLC (the “Company”), stepped down from such roles at the Company.
Departed

Andrew Broderick

director
ULCC · Frontier Group Holdings, Inc.
Effective
2026-06-15
Successor
Barron Steele
Filed
June 12, 2026, 4:15 PM ET
On June 9, 2026, Andrew Broderick announced his intention to resign from the Board of Directors (the “Board”) of Frontier Group Holdings, Inc. (the “Company”), effective June 15, 2026
Departed

Tim Walbert

Board Member
SGMT · Sagimet Biosciences Inc.
Effective
2026-06-12
Filed
June 12, 2026, 4:06 PM ET
On June 12, 2026, Tim Walbert, a member of the Board of Directors (the “Board”) of Sagimet Biosciences Inc. (the “Company”), tendered his resignation from the Board, effective as of June 12, 2026.
Departed

Richard C. Straube

Consulting Chief Medical Officer
SNGX · SOLIGENIX, INC.
Effective
2026-06-11
Filed
June 12, 2026, 4:05 PM ET
Dr. Straube ceased serving as the Company's Consulting Chief Medical Officer.
Departed

Kevin Mills

President and Chief Executive Officer
SCKT · SOCKET MOBILE, INC.
Successor
David A. Holmes
Filed
June 12, 2026, 4:05 PM ET
On June 8, 2026, the independent members of the Board of Directors (the “Board”) of Socket Mobile, Inc. (the “Company”) notified Kevin Mills of the Board’s decision to remove him from his role as President and Chief Executive Officer of the Company.
Departed

Jeffrey T. Welch

Chief Legal Officer
RRR · Red Rock Resorts, Inc.
Effective
2026-09-08
Successor
J. Colby Williams
Filed
June 12, 2026, 4:02 PM ET
On June 12, 2026, Red Rock Resorts, Inc. and Station Casinos LLC (together, the “Company”) announced that Jeffrey T. Welch is retiring and will step down from his role as Chief Legal Officer of the Company effective September 8, 2026.
Departed

Frank Galea

Chief Compliance Officer
Remora Capital Corp
Effective
2026-06-12
Successor
Heather Birmingham
Filed
June 12, 2026, 3:00 PM ET
On May 29, 2026, Frank Galea submitted a notice of his intention to retire from his position as the Chief Compliance Officer of Remora Capital Corporation (the “Company”), effective as of June 12, 2026.
Departed

Donald Poulton

Chief Executive Officer
MFIN · MEDALLION FINANCIAL CORP
Effective
2026-06-30
Successor
David Justin Haley
Filed
June 12, 2026, 8:30 AM ET
On June 11, 2026, Mr. Donald Poulton notified Medallion Financial Corp. and Medallion Bank of his intention to retire from his position as Chief Executive Officer of Medallion Bank, effective June 30, 2026.
Departed

Jason Pernell

President
TCNNF · Trulieve Cannabis Corp.
Effective
2026-06-11
Filed
June 12, 2026, 8:12 AM ET
On June 11, 2026 (the “Termination Date”), the Company and Jason Pernell mutually agreed that Mr. Pernell shall terminate his employment his position of President of Trulieve Cannabis Corp. (the “Company”) effective immediately.
Departed

Michael Amoroso

Director
ABEO · ABEONA THERAPEUTICS INC.
Effective
2026-06-11
Filed
June 12, 2026, 7:30 AM ET
On June 11, 2026, Michael Amoroso resigned as a member of the Board of Directors (the “Board”) of Abeona Therapeutics Inc. (the “Company”) effective immediately.
Departed

William Conkling

Executive Vice President and Chief Financial Officer
INN · Summit Hotel Properties, Inc.
Effective
2026-06-15
Successor
Jonathan Stanner
Filed
June 12, 2026, 6:36 AM ET
On June 12, 2026, Summit Hotel Properties, Inc. (the “Company”) announced that William Conkling, the Company’s Executive Vice President and Chief Financial Officer, has resigned as an officer and employee of the Company effective as of June 15, 2026
Departed (interim)

Bryan D. Coy

Executive Vice President and Chief Financial Officer
CNNE · Cannae Holdings, Inc.
Effective
2026-06-10
Successor
Brett A. Correia
Filed
June 11, 2026, 6:25 PM ET
On June 10, 2026, Bryan D. Coy resigned from his position as Executive Vice President and Chief Financial Officer of Cannae Holdings, Inc.
Departed

Daniel M. McCabe

member of the Board of Directors
GLND · Greenland Energy Co
Effective
2026-06-05
Successor
Carol Craig
Filed
June 11, 2026, 5:20 PM ET
On June 5, 2026, Daniel M. McCabe notified Greenland Energy Company, a Texas corporation (the “Company”), of his resignation from his position as a member of the Board of Directors (the “Board”) of the Company, effective immediately.
Departed

Viktor Balan

President, Secretary, Treasurer, Chief Executive Officer, and a member of the Board of Directors
STWI · StageWise Strategies Corp.
Effective
2026-06-05
Filed
June 11, 2026, 5:15 PM ET
Viktor Balan resigned from his positions as President, Secretary, Treasurer, Chief Executive Officer and a member of the Board of Directors of the Company (the “Board”), and Alarcon Martinez Marcelo Ramon and Anna Toczko each resigned as a member of the Board, each effective as of June 5, 2026.
Departed

Alarcon Martinez Marcelo Ramon

member of the Board of Directors
STWI · StageWise Strategies Corp.
Effective
2026-06-05
Filed
June 11, 2026, 5:15 PM ET
and Alarcon Martinez Marcelo Ramon and Anna Toczko each resigned as a member of the Board, each effective as of June 5, 2026.
Departed

Anna Toczko

member of the Board of Directors
STWI · StageWise Strategies Corp.
Effective
2026-06-05
Filed
June 11, 2026, 5:15 PM ET
and Alarcon Martinez Marcelo Ramon and Anna Toczko each resigned as a member of the Board, each effective as of June 5, 2026.
Departed

Irwin Katsof

Director
IDT · IDT CORP
Effective
2026-06-09
Successor
William Conkling
Filed
June 11, 2026, 5:03 PM ET
On June 9 2026, Irwin Katsof notified IDT Corporation (the “Company”) of his resignation from the board of directors of the Company (the “Board”) and the respective committees of the Board on which he served.
Departed

E. Ted Botner

Executive Vice President, General Counsel and Corporate Secretary
MUR · MURPHY OIL CORP
Effective
2026-06-11
Successor
Roger W. Landes
Filed
June 11, 2026, 4:47 PM ET
E. Ted Botner, Executive Vice President, General Counsel and Corporate Secretary, will retire from his position as Executive Vice President, General Counsel and Corporate Secretary, effective immediately, and will retire from the Company on June 30, 2026.
Departed

William Fairey

Director
KALV · KalVista Pharmaceuticals, Inc.
Effective
2026-06-11
Successor
John Hess
Filed
June 11, 2026, 4:44 PM ET
each of Brian J. G. Pereira, MD, Benjamin L. Palleiko, William Fairey, Laurence Reid, PhD, Bethany Sensenig, Nancy Stuart, Patrick Treanor and Edward W. Unkart resigned from his or her respective positions as a member of the Company’s board of directors
Departed

Patrick Treanor

Director
KALV · KalVista Pharmaceuticals, Inc.
Effective
2026-06-11
Successor
John Hess
Filed
June 11, 2026, 4:44 PM ET
each of Brian J. G. Pereira, MD, Benjamin L. Palleiko, William Fairey, Laurence Reid, PhD, Bethany Sensenig, Nancy Stuart, Patrick Treanor and Edward W. Unkart resigned from his or her respective positions as a member of the Company’s board of directors
Departed

Brian J. G. Pereira, MD

Director
KALV · KalVista Pharmaceuticals, Inc.
Effective
2026-06-11
Successor
John Hess
Filed
June 11, 2026, 4:44 PM ET
each of Brian J. G. Pereira, MD, Benjamin L. Palleiko, William Fairey, Laurence Reid, PhD, Bethany Sensenig, Nancy Stuart, Patrick Treanor and Edward W. Unkart resigned from his or her respective positions as a member of the Company’s board of directors
Departed

Bethany Sensenig

Director
KALV · KalVista Pharmaceuticals, Inc.
Effective
2026-06-11
Successor
John Hess
Filed
June 11, 2026, 4:44 PM ET
each of Brian J. G. Pereira, MD, Benjamin L. Palleiko, William Fairey, Laurence Reid, PhD, Bethany Sensenig, Nancy Stuart, Patrick Treanor and Edward W. Unkart resigned from his or her respective positions as a member of the Company’s board of directors
Departed

Edward W. Unkart

Director
KALV · KalVista Pharmaceuticals, Inc.
Effective
2026-06-11
Successor
John Hess
Filed
June 11, 2026, 4:44 PM ET
each of Brian J. G. Pereira, MD, Benjamin L. Palleiko, William Fairey, Laurence Reid, PhD, Bethany Sensenig, Nancy Stuart, Patrick Treanor and Edward W. Unkart resigned from his or her respective positions as a member of the Company’s board of directors
Departed

Laurence Reid, PhD

Director
KALV · KalVista Pharmaceuticals, Inc.
Effective
2026-06-11
Successor
John Hess
Filed
June 11, 2026, 4:44 PM ET
each of Brian J. G. Pereira, MD, Benjamin L. Palleiko, William Fairey, Laurence Reid, PhD, Bethany Sensenig, Nancy Stuart, Patrick Treanor and Edward W. Unkart resigned from his or her respective positions as a member of the Company’s board of directors
Departed

Benjamin L. Palleiko

Director
KALV · KalVista Pharmaceuticals, Inc.
Effective
2026-06-11
Successor
John Hess
Filed
June 11, 2026, 4:44 PM ET
each of Brian J. G. Pereira, MD, Benjamin L. Palleiko, William Fairey, Laurence Reid, PhD, Bethany Sensenig, Nancy Stuart, Patrick Treanor and Edward W. Unkart resigned from his or her respective positions as a member of the Company’s board of directors
Departed

Nancy Stuart

Director
KALV · KalVista Pharmaceuticals, Inc.
Effective
2026-06-11
Successor
John Hess
Filed
June 11, 2026, 4:44 PM ET
each of Brian J. G. Pereira, MD, Benjamin L. Palleiko, William Fairey, Laurence Reid, PhD, Bethany Sensenig, Nancy Stuart, Patrick Treanor and Edward W. Unkart resigned from his or her respective positions as a member of the Company’s board of directors
Departed

Daniel Durn

member of our board of directors and Chair of the Audit Committee
MRVL · Marvell Technology, Inc.
Effective
2026-06-10
Filed
June 11, 2026, 4:33 PM ET
On June 10, 2026, Daniel Durn, a member of our board of directors (the "Board") and Chair of the Audit Committee, resigned from the Board, including from all committees of the Board on which he served, effective immediately, and was subsequently appointed by the Board to serve as the Company’s Chief Financial Officer and Executive Vice President and principal financial officer, effective June 15, 2026.
Departed

Willem Meintjes

Chief Financial Officer and Executive Vice President
MRVL · Marvell Technology, Inc.
Effective
2026-06-15
Successor
Daniel Durn
Filed
June 11, 2026, 4:33 PM ET
On June 11, 2026, Marvell Technology, Inc. (the "Company") announced that Willem Meintjes, the Company’s Chief Financial Officer and Executive Vice President, notified the Company on June 10, 2026 of his decision to resign from his position effective as of June 15, 2026.
Departed

Greg Tourangeau

Vice President, Finance and principal accounting officer
FULC · Fulcrum Therapeutics, Inc.
Filed
June 11, 2026, 4:30 PM ET
On June 10, 2026, Fulcrum and Greg Tourangeau, Fulcrum’s Vice President, Finance and principal accounting officer, mutually agreed that Mr. Tourangeau will depart from his position at Fulcrum on a date to be agreed between Mr. Tourangeau and Fulcrum.
Departed

Philip R. Martens

Chairman of the Board
GPK · GRAPHIC PACKAGING HOLDING CO
Effective
2026-06-11
Successor
Larry M. Venturelli
Filed
June 11, 2026, 4:30 PM ET
Effective June 11, 2026, following the Annual Meeting of Stockholders, Mr. Philip R. Martens retired from his positions as a member and Chairman of the Board of Directors (the “Board”) of Graphic Packaging Holding Company (the “Company”).
Departed

Jeffrey S. Lorberbaum

Chief Executive Officer
MHK · MOHAWK INDUSTRIES INC
Effective
2026-09-30
Successor
Paul F. De Cock
Filed
June 11, 2026, 4:16 PM ET
Mr. De Cock will succeed Jeffrey S. Lorberbaum, who will retire from his role as CEO of the Company at that time
Departed

Tatiana Segal

director of the Delegated Sponsor
MSBT · Morgan Stanley Bitcoin Trust
Effective
2026-05-07
Filed
June 11, 2026, 4:15 PM ET
Tatiana Segal notified the Delegated Sponsor of her intention to resign from her position as a director of the Delegated Sponsor effective May 7, 2026.
Departed

Ruairi O'Healai

director of the Delegated Sponsor
MSBT · Morgan Stanley Bitcoin Trust
Effective
2026-06-05
Filed
June 11, 2026, 4:15 PM ET
Ruairi O’Healai notified Morgan Stanley Investment Management Inc., the delegated sponsor of Morgan Stanley Bitcoin Trust (the “Delegated Sponsor”), of his intention to resign from his position as a director of the Delegated Sponsor effective June 5, 2026.
Departed

Ranjeev Krishana

Director
ONC · BeOne Medicines Ltd.
Effective
2026-06-11
Filed
June 11, 2026, 4:13 PM ET
Mr. Michael Goller, Mr. Ranjeev Krishana, Dr. Corazon (Corsee) D. Sanders and Mr. Qingqing Yi, whose terms expired at the Annual Meeting, did not stand for re-election at the Annual Meeting.
Departed

Qingqing Yi

Director
ONC · BeOne Medicines Ltd.
Effective
2026-06-11
Filed
June 11, 2026, 4:13 PM ET
Mr. Michael Goller, Mr. Ranjeev Krishana, Dr. Corazon (Corsee) D. Sanders and Mr. Qingqing Yi, whose terms expired at the Annual Meeting, did not stand for re-election at the Annual Meeting.
Departed

Corazon (Corsee) D. Sanders

Director
ONC · BeOne Medicines Ltd.
Effective
2026-06-11
Filed
June 11, 2026, 4:13 PM ET
Mr. Michael Goller, Mr. Ranjeev Krishana, Dr. Corazon (Corsee) D. Sanders and Mr. Qingqing Yi, whose terms expired at the Annual Meeting, did not stand for re-election at the Annual Meeting.
Departed

Michael Goller

Director
ONC · BeOne Medicines Ltd.
Effective
2026-06-11
Filed
June 11, 2026, 4:13 PM ET
Mr. Michael Goller, Mr. Ranjeev Krishana, Dr. Corazon (Corsee) D. Sanders and Mr. Qingqing Yi, whose terms expired at the Annual Meeting, did not stand for re-election at the Annual Meeting.
Departed

Daniel Durn

Chief Financial Officer and Executive Vice President, Finance, Technology, Security and Operations
ADBE · ADOBE INC.
Effective
2026-06-15
Successor
Steven Day
Filed
June 11, 2026, 4:08 PM ET
On June 8, 2026, Daniel Durn notified the Company of his decision to resign as Chief Financial Officer and Executive Vice President, Finance, Technology, Security and Operations, effective June 15, 2026.
Departed

Eric Kash

Executive Vice President and Director
CJMB · CALLAN JMB INC.
Effective
2026-06-05
Filed
June 11, 2026, 4:01 PM ET
On June 5, 2026, Eric Kash resigned from his position as Executive Vice President of Callan JMB Inc. (the “Company”), and from his position as a member of the Board of Directors of the Company, including any committee positions, effective as of June 5, 2026.
Departed

Russell R. Shaller

President and Chief Executive Officer
BRC · BRADY CORP
Effective
2026-06-08
Successor
Vineet Nargolwala
Filed
June 11, 2026, 3:01 PM ET
On June 8, 2026, Brady Corporation (the “Company”) announced that Russell R. Shaller will be retiring as the Company’s President and Chief Executive Officer, effective June 8, 2026 (the “Effective Date”).
Departed

Christodoulos Tzoutzakis

Chief Operating Officer and Chief Technology Officer
ELVG · Elvictor Group, Inc.
Effective
2026-06-11
Filed
June 11, 2026, 2:23 PM ET
Effective June 11, 2026, the Board of Directors (the “Board”) of Elvictor Group, Inc. (the “Company”) removed without cause Christodoulos Tzoutzakis as the Company’s Chief Operating Officer and Chief Technology Officer.

Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.